{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T06:13:23Z","timestamp":1740809603801,"version":"3.38.0"},"reference-count":35,"publisher":"Center for Academic Publications Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nutr Sci Vitaminol","JNSV","Journal of Nutritional Science and Vitaminology, J Nutr Sci Vitaminol","Journal of Nutritional Science and Vitaminology"],"published-print":{"date-parts":[[2025,2,28]]},"DOI":"10.3177\/jnsv.71.34","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:17:52Z","timestamp":1740694672000},"page":"34-45","source":"Crossref","is-referenced-by-count":0,"title":["A Compound Nutritional Supplement Relieving the Core Symptoms of Autism Rats"],"prefix":"10.3177","volume":"71","author":[{"given":"Xinrong","family":"PAN","sequence":"first","affiliation":[{"name":"School of Pharmacy, Xuzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoyao","family":"XIU","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Xuzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiting","family":"HUANG","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Xuzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjie","family":"LAI","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Xuzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxue","family":"WANG","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Xuzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhui","family":"CAO","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Xuzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"JIANG","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Xuzhou Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1759","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. 2018. Autism spectrum disorder. Lancet 392(10146): 508-520.","DOI":"10.1016\/S0140-6736(18)31129-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Salari N, Rasoulpoor S, Rasoulpoor S, Shohaimi S, Jafarpour S, Abdoli N, Khaledi-Paveh B, Mohammadi M. 2022. The global prevalence of autism spectrum disorder: a comprehensive systematic review and meta-analysis. Ital J Pediatr 48(1): 112-127.","DOI":"10.1186\/s13052-022-01310-w"},{"key":"3","unstructured":"3) Posar A, Visconti P. 2023. Autism spectrum disorder in 2023: A challenge still open. Turk Arch Pediatr 58(6): 566-571."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Loffi RG, Cruz TKF, Paiva GM, Souto DO, Barreto SR, Santana PAN, Nascimento A, Costa FRM, Cota EB, Haase VG. 2024. Theoretical-methodological foundations for the global integration method (Metodo de Integracao Global-MIG) in the treatment of autism spectrum disorder. Children (Basel) 11(2): 191-220.","DOI":"10.3390\/children11020191"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) De Sales-Millan A, Aguirre-Garrido JF, Gonzalez-Cervantes RM, Velazquez-Aragon JA. 2023. Microbiome-gut-mucosal-immune-brain axis and autism spectrum disorder (ASD): A novel proposal of the role of the gut microbiome in ASD aetiology. Behav Sci (Basel) 13(7): 548-568.","DOI":"10.3390\/bs13070548"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Wang Y, Kasper LH. 2014. The role of microbiome in central nervous system disorders. Brain Behav Immun 38: 1-12.","DOI":"10.1016\/j.bbi.2013.12.015"},{"key":"7","unstructured":"7) Carabotti M, Scirocco A, Maselli MA, Severi C. 2015. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28(2): 203-209."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Iglesias-Vazquez L, Van Ginkel Riba G, Arija V, Canals J. 2020. Composition of gut microbiota in children with autism spectrum disorder: A systematic review and meta-analysis. Nutrients 12(3): 792-811.","DOI":"10.3390\/nu12030792"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Buie T, Campbell DB, Fuchs GJ, 3rd, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL, Carr EG, Gershon MD, Hyman SL, Jirapinyo P, Jyonouchi H, Kooros K, Kushak R, Levitt P, Levy SE, Lewis JD, Murray KF, Natowicz MR, Sabra A, Wershil BK, Weston SC, Zeltzer L, Winter H. 2010. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125(Suppl 1): S1-18.","DOI":"10.1542\/peds.2009-1878C"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Shaaban SY, El Gendy YG, Mehanna NS, El-Senousy WM, El-Feki HSA, Saad K, El-Asheer OM. 2018. The role of probiotics in children with autism spectrum disorder: A prospective, open-label study. Nutr Neurosci 21(9): 676-681.","DOI":"10.1080\/1028415X.2017.1347746"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Zhu J, Hua X, Yang T, Guo M, Li Q, Xiao L, Li L, Chen J, Li T. 2022. Alterations in gut vitamin and amino acid metabolism are associated with symptoms and neurodevelopment in children with autism spectrum disorder. J Autism Dev Disord 52(7): 3116-3128.","DOI":"10.1007\/s10803-021-05066-w"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Guo M, Li L, Zhang Q, Chen L, Dai Y, Liu L, Feng J, Cai X, Cheng Q, Chen J, Wei H, Li T. 2020. Vitamin and mineral status of children with autism spectrum disorder in Hainan Province of China: associations with symptoms. Nutr Neurosci 23(10): 803-810.","DOI":"10.1080\/1028415X.2018.1558762"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Esteban-Figuerola P, Canals J, Fernandez-Cao JC, Arija Val V. 2019. Differences in food consumption and nutritional intake between children with autism spectrum disorders and typically developing children: A meta-analysis. Autism 23(5): 1079-1095.","DOI":"10.1177\/1362361318794179"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Dhir S, Tarasenko M, Napoli E, Giulivi C. 2019. Neurological, psychiatric, and biochemical aspects of thiamine deficiency in children and adults. Front Psychiatry 10(207): 1-15.","DOI":"10.3389\/fpsyt.2019.00207"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Lelord G, Muh JP, Barthelemy C, Martineau J, Garreau B, Callaway E. 1981. Effects of pyridoxine and magnesium on autistic symptoms\u2014initial observations. J Autism Dev Disord 11(2): 219-230.","DOI":"10.1007\/BF01531686"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Rossignol DA, Frye RE. 2014. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front Physiol 5(150): 1-15.","DOI":"10.3389\/fphys.2014.00150"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Vogel T, Dali-Youcef N, Kaltenbach G, Andres E. 2009. Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Pract 63(7): 1061-1067.","DOI":"10.1111\/j.1742-1241.2009.02026.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hendren RL, James SJ, Widjaja F, Lawton B, Rosenblatt A, Bent S. 2016. Randomized, placebo-controlled trial of methyl B12 for children with autism. J Child Adolesc Psychopharmacol 26(9): 774-783.","DOI":"10.1089\/cap.2015.0159"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Lisi G, Ribolsi M, Siracusano A, Niolu C. 2020. Maternal vitamin D and its role in determining fetal origins of mental health. Curr Pharm Des 26(21): 2497-2509.","DOI":"10.2174\/1381612826666200506093858"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Rossignol DA, Frye RE. 2021. Cerebral folate deficiency, folate receptor alpha autoantibodies and leucovorin (folinic acid) treatment in autism spectrum disorders: A systematic review and meta-analysis. J Pers Med 11(11): 1141-1162.","DOI":"10.3390\/jpm11111141"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Trudeau MS, Madden RF, Parnell JA, Gibbard WB, Shearer J. 2019. Dietary and supplement-based complementary and alternative medicine use in pediatric autism spectrum disorder. Nutrients 11(8): 1783-1793.","DOI":"10.3390\/nu11081783"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Marcondes FK, Bianchi FJ, Tanno AP. 2002. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 62(4A): 609-614.","DOI":"10.1590\/S1519-69842002000400008"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Schneider T, Przewlocki R. 2005. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30(1): 80-89.","DOI":"10.1038\/sj.npp.1300518"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Seibenhener ML, Wooten MC. 2015. Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp (96): e52434.","DOI":"10.3791\/52434"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nakhal MM, Jayaprakash P, Aburuz S, Sadek B, Akour A. 2023. Canagliflozin ameliorates oxidative stress and autistic-like features in valproic-acid-induced autism in rats: Comparison with aripiprazole action. Pharmaceuticals (Basel) 16(5): 769-786.","DOI":"10.3390\/ph16050769"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Shoji H, Miyakawa T. 2019. Age-related behavioral changes from young to old age in male mice of a C57BL\/6J strain maintained under a genetic stability program. Neuropsychopharmacol Rep 39(2): 100-118.","DOI":"10.1002\/npr2.12052"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yang YW, Chen MK, Yang BY, Huang XJ, Zhang XR, He LQ, Zhang J, Hua ZC. 2015. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in mouse feces. Appl Environ Microbiol 81(19): 6749-6756.","DOI":"10.1128\/AEM.01906-15"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Joshi A, Denovellis EL, Mankili A, Meneksedag Y, Davidson TJ, Gillespie AK, Guidera JA, Roumis D, Frank LM. 2023. Dynamic synchronization between hippocampal representations and stepping. Nature 617(7959): 125-131.","DOI":"10.1038\/s41586-023-05928-6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Borges-Vieira JG, Cardoso CKS. 2023. Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials. Nutr Neurosci 26(3): 187-207.","DOI":"10.1080\/1028415X.2022.2031494"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Taniya MA, Chung HJ, Al Mamun A, Alam S, Aziz MA, Emon NU, Islam MM, Hong SS, Podder BR, Ara Mimi A, Aktar Suchi S, Xiao J. 2022. Role of gut microbiome in autism spectrum disorder and its therapeutic regulation. Front Cell Infect Microbiol 12: 915701.","DOI":"10.3389\/fcimb.2022.915701"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Halladay AK, Bishop S, Constantino JN, Daniels AM, Koenig K, Palmer K, Messinger D, Pelphrey K, Sanders SJ, Singer AT, Taylor JL, Szatmari P. 2015. Sex and gender differences in autism spectrum disorder: summarizing evidence gaps and identifying emerging areas of priority. Mol Autism 6(36): 1-5.","DOI":"10.1186\/s13229-015-0019-y"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Wohlgemuth KJ, Arieta LR, Brewer GJ, Hoselton AL, Gould LM, Smith-Ryan AE. 2021. Sex differences and considerations for female specific nutritional strategies: a narrative review. J Int Soc Sports Nutr 18(1): 27-46.","DOI":"10.1186\/s12970-021-00422-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Moradi H, Sohrabi M, Taheri H, Khodashenas E, Movahedi A. 2018. Comparison of the effects of perceptual-motor exercises, vitamin D supplementation and the combination of these interventions on decreasing stereotypical behavior in children with autism disorder. Int J Dev Disabil 66(2): 122-132.","DOI":"10.1080\/20473869.2018.1502068"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Tardy AL, Pouteau E, Marquez D, Yilmaz C, Scholey A. 2020. Vitamins and minerals for energy, fatigue and cognition: A narrative review of the biochemical and clinical evidence. Nutrients 12(1): 228-262.","DOI":"10.3390\/nu12010228"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Ukkirapandian K, Kayalvizhi E, Udaykumar KP, Kandhi S, Muthulakshmi R. 2022. The neuroprotective role of Acorus calamus in developmental and histopathological changes in autism-induced wistar rats. Cureus 14(9): e29717.","DOI":"10.7759\/cureus.29717"}],"container-title":["Journal of Nutritional Science and Vitaminology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/71\/1\/71_34\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T03:51:43Z","timestamp":1740801103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/71\/1\/71_34\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3177\/jnsv.71.34","relation":{},"ISSN":["0301-4800","1881-7742"],"issn-type":[{"type":"print","value":"0301-4800"},{"type":"electronic","value":"1881-7742"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}